Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
26.5M
-
Number of holders
-
73
-
Total 13F shares, excl. options
-
6.46M
-
Shares change
-
+352K
-
Total reported value, excl. options
-
$82.6M
-
Value change
-
+$4.56M
-
Put/Call ratio
-
0.59
-
Number of buys
-
38
-
Number of sells
-
-19
-
Price
-
$12.80
Significant Holders of AVITA Medical, Inc. - Common Stock (RCEL) as of Q4 2024
83 filings reported holding RCEL - AVITA Medical, Inc. - Common Stock as of Q4 2024.
AVITA Medical, Inc. - Common Stock (RCEL) has 73 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.46M shares
of 26.5M outstanding shares and own 24.38% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (1.87M shares), VANGUARD GROUP INC (1.42M shares), GEODE CAPITAL MANAGEMENT, LLC (598K shares), STATE STREET CORP (535K shares), ESSEX INVESTMENT MANAGEMENT CO LLC (261K shares), NORTHERN TRUST CORP (229K shares), GOLDMAN SACHS GROUP INC (175K shares), UBS Group AG (129K shares), AWM Investment Company, Inc. (98.2K shares), and MORGAN STANLEY (84.9K shares).
This table shows the top 73 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.